Table 1 Patient characteristics
From: Response to imatinib as a function of target kinase expression in recurrent glioblastoma
Primary GBM | 24 (100%) |
|---|---|
Sex – n (%) | |
Female | 11 (45%) |
Male | 13 (55%) |
Age – yr | |
Median (Range) | 53 (18 – 72y) |
Performance score – n (%) | |
WHO 0 | 0 |
WHO I | 16 (65%) |
WHO II | 8 (33%) |
Extent of surgery – n (%) | |
Biopsy | 3 (12.5%) |
Partial resection | 11 (46%) |
Gross total resection | 10 (41.5%) |
Previous chemotherapies | |
1 | 11 (46%) |
2 | 9 (36%) |
3 | 2 (3.5%) |
4 | 2 (3.5%) |
Antiepileptic drugs | |
None | 10 (41.5%) |
EIAEDs | 10 (41.5%) |
Non-EIAEDs | 4 (18%) |